Your browser doesn't support javascript.
loading
New Treatment Options in Metastatic Pancreatic Cancer.
Fudalej, Marta; Kwasniewska, Daria; Nurzynski, Pawel; Badowska-Kozakiewicz, Anna; Mekal, Dominika; Czerw, Aleksandra; Sygit, Katarzyna; Deptala, Andrzej.
Afiliación
  • Fudalej M; Department of Oncology Propaedeutics, Medical University of Warsaw, 01-445 Warsaw, Poland.
  • Kwasniewska D; Department of Oncology, Central Clinical Hospital of the Ministry of Interior and Administration, 02-507 Warsaw, Poland.
  • Nurzynski P; Department of Oncology, Central Clinical Hospital of the Ministry of Interior and Administration, 02-507 Warsaw, Poland.
  • Badowska-Kozakiewicz A; Department of Oncology, Central Clinical Hospital of the Ministry of Interior and Administration, 02-507 Warsaw, Poland.
  • Mekal D; Department of Oncology Propaedeutics, Medical University of Warsaw, 01-445 Warsaw, Poland.
  • Czerw A; Department of Oncology Propaedeutics, Medical University of Warsaw, 01-445 Warsaw, Poland.
  • Sygit K; Department of Health Economics and Medical Law, Medical University of Warsaw, 01-445 Warsaw, Poland.
  • Deptala A; Department of Economic and System Analyses, National Institute of Public Health NIH-National Research Institute, 00-791 Warsaw, Poland.
Cancers (Basel) ; 15(8)2023 Apr 17.
Article en En | MEDLINE | ID: mdl-37190255
Pancreatic cancer (PC) is the seventh leading cause of cancer death across the world. Poor prognosis of PC is associated with several factors, such as diagnosis at an advanced stage, early distant metastases, and remarkable resistance to most conventional treatment options. The pathogenesis of PC seems to be significantly more complicated than originally assumed, and findings in other solid tumours cannot be extrapolated to this malignancy. To develop effective treatment schemes prolonging patient survival, a multidirectional approach encompassing different aspects of the cancer is needed. Particular directions have been established; however, further studies bringing them all together and connecting the strengths of each therapy are needed. This review summarises the current literature and provides an overview of new or emerging therapeutic strategies for the more effective management of metastatic PC.
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Cancers (Basel) Año: 2023 Tipo del documento: Article País de afiliación: Polonia Pais de publicación: Suiza